COPD Calls For Volunteers

Posted on January 20, 2016
Archive : January 2016
Category : News

Calls for volunteers to take part in study to help fight one of UK's biggest killers!

Smokers and former smokers alike are being urged to volunteer their help in the fight against one of the nation’s biggest killers – COPD or chronic obstructive pulmonary disease.

The appeal comes from leading clinical research specialist MeDiNova and follows the new-year launch of a national campaign by Public Health England which aims to highlight the debilitating nature of lung disease, for which smoking is the biggest and most preventable risk factor.

Latest GP figures show that more than one million people in England alone are battling COPD.

Causing around 25,000 deaths each year, COPD poses a huge threat to public health. Medical experts believe almost 90 per cent of deaths from COPD are the direct result of smoking.

Many patients are unaware of the risks of COPD and as a result ignore early warning signs, which they often dismiss as smoker’s cough.

Consequently, hospitals in England dealt with more 113,000 emergency admissions during 2013 and 2014, as the COPD left sufferers fighting for breath, battling a persistent cough or suffering frequent chest infections.

Affecting smokers and former smokers alike, there is no cure for COPD. But the sooner the condition is diagnosed and treatment begins, the less chance the long-term impact on the lungs

MeDiNova Research, which has sites in Sidcup in Kent, Romford, Essex and Northwood, North London is embarking on a study which is aimed at relieving systems. 

The study is open to patients already diagnosed with COPD, aims to evaluate the effect of aclidinium bromide in the relief of COPD symptoms.

It is open to smokers or former smokers alike, who have either never suffered an attack, or who have not suffered an attack in the past 12 months. Volunteers must be at least 40 years old.

Kumar Muthalagappan, Chief Executive of MeDiNova, said: “The various treatments we have on the market already have all resulted from previous studies such as the one we are about to launch.

“But screenings such as these are vital in the ongoing fight to continue improving treatment for this awful disease, which claims tens of thousands of lives each year.

“The study enable us to educate ourselves through our ongoing programme of research and of course our professional team of research investigators, doctors, nurses and other staff provide first class support to ensure the well-being of each and every patient at all times.”